WELL Health Reports Record Revenue and Adjusted EBITDA Results for Q3 2022 and Raises Guidance for.

VANCOUVER, BC: WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its results for the fiscal third quarter ended September 30, 2022.

Hamed Shahbazi, Chairman and CEO of WELL commented, "We had a great quarter achieving 'best ever' results on both revenue and Adjusted EBITDA(2) line without even being in our seasonally strongest quarter. These exemplary results were once again driven by strong operating performances across all our lines of business including on and offline channels reflecting robust operating margins and organic growth of over 18% YoY. Organic growth in our Virtual Services was especially strong at 75%, making Virtual Services now our single largest line of business by revenue, larger now than our CRH or our Canadian Clinics businesses which both continue to grow and perform nicely. WELL also achieved record patient engagement in the quarter with over 1.25 million combined omni-channel, diagnostic and asynchronous patient interactions - representing an annual run-rate of approximately 5.0 million patient interactions system wide. WELL's US-based virtual patient services businesses, Circle Medical and Wisp, achieved profitable results and continued growth in revenues with a combined annual revenue run-rate exceeding US$100 million in Q3, which was one quarter earlier than our prior forecast. We have worked hard to align ourselves closely to the success of care providers and doing everything we can to further their success. That is what makes the success of these record results so special. We don't prosper or succeed unless our care provider partners do. Our outlook for the fourth quarter remains very positive, hence we are able to confidently increase our annual guidance for annual revenue to exceed $565 million in 2022."

Third Quarter 2022 Financial Highlights:

WELL achieved record quarterly revenue of $145.8 million in Q3-2022, compared to revenue of $99.3 million generated during Q3-2021, an increase of 47% driven by acquisitions during the past year and organic growth.

Omni-channel Patient Services revenue increased 15% to $93.6 million in Q3-2022, compared to $81.3 million in Q3-2021.

Virtual Services revenues increased 191% to $52.2 million in Q3-2022, compared to Virtual Services revenue of $18.0...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT